| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |